BiotechTube
Home/Thetis Pharmaceuticals/John Parkinson, PhD
JP

John Parkinson, PhD

Chief Science Officer

Thetis Pharmaceuticals

Therapeutic Areas

Gastroenterology (IBD)Oncology

Thetis Pharmaceuticals Pipeline

DrugIndicationPhase
TP-317Ulcerative Colitis (Inflammatory Bowel Disease)Phase 1b

Leadership Team at Thetis Pharmaceuticals

GM
Gary Mathias
Co-Founder and CEO
JS
Joyce Steinberg, MD, FACP
Chief Medical Officer
BP
Beverly Paperiello
SVP, Development Operations
View full Thetis Pharmaceuticals profile